These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1998994)

  • 21. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.
    Los G; Verdegaal EM; Mutsaers PH; McVie JG
    Cancer Chemother Pharmacol; 1991; 28(3):159-65. PubMed ID: 1855272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
    Stewart DJ; Molepo JM; Green RM; Montpetit VA; Hugenholtz H; Lamothe A; Mikhael NZ; Redmond MD; Gadia M; Goel R
    Br J Cancer; 1995 Mar; 71(3):598-604. PubMed ID: 7880744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats.
    Los G; Sminia P; Wondergem J; Mutsaers PH; Havemen J; ten Bokkel Huinink D; Smals O; Gonzalez-Gonzalez D; McVie JG
    Eur J Cancer; 1991; 27(4):472-7. PubMed ID: 1827723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and tissue chamber fluid platinum concentrations released from cis-diamminedichloroplatinum II-impregnated polymethylmethacrylate in healthy dogs.
    Buss MS; Henry CJ; Tyler JW; Tobias KS; Daoud S; Hoopes J; Moore MP
    Am J Vet Res; 1999 Mar; 60(3):280-3. PubMed ID: 10188807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).
    Perera A; Jackson H; Sharma HL; McAuliffe CA; Fox BW
    Chem Biol Interact; 1992 Dec; 85(2-3):199-213. PubMed ID: 1493609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
    Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC
    Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
    Douple EB; Totten MD; Spencer F
    NCI Monogr; 1988; (6):129-32. PubMed ID: 3281028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
    Kigawa J; Minagawa Y; Itamochi H; Kanamori Y; Ishihara H; Terakawa N
    Obstet Gynecol; 1995 Aug; 86(2):265-8. PubMed ID: 7617358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice.
    Korst AE; Boven E; van der Sterre ML; Fichtinger-Schepman AM; van der Vijgh WJ
    Eur J Cancer; 1998 Feb; 34(3):412-6. PubMed ID: 9640232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans.
    Fournier C; Vennin P; Hecquet B
    Cancer Chemother Pharmacol; 1988; 21(1):75-7. PubMed ID: 3342469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.
    Fulco RA; Vannozzi M; Collecchi P; Merlo F; Parodi B; Civalleri D; Esposito M
    Anticancer Res; 1990; 10(6):1603-10. PubMed ID: 2285232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo sustained release of cisplatin from bioresorbable implants in mice.
    Hecquet B; Chabot F; Delatorre Gonzalez JC; Fournier C; Hilali S; Cambier L; Depadt G; Vert M
    Anticancer Res; 1986; 6(5):1251-5. PubMed ID: 3800332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of platinum in the brain of mice treated with cisplatin and subjected to short-term hypoxia.
    Minami T; Ichii M; Okazaki Y
    J Pharm Pharmacol; 1996 May; 48(5):505-9. PubMed ID: 8799875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional pharmacokinetic selectivity of intrapleural cisplatin.
    Bogliolo GV; Lerza R; Bottino GB; Mencoboni MP; Pannacciulli IM; Vannozzi M; Fulco RA; Merlo F; Esposito M
    Eur J Cancer; 1991; 27(7):839-42. PubMed ID: 1834113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.
    van Hennik MB; van der Vijgh WJ; Klein I; Elferink F; Vermorken JB; Winograd B; Pinedo HM
    Cancer Res; 1987 Dec; 47(23):6297-301. PubMed ID: 3315183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ; Yu WD; Reyno LM; Modzelewski RA; Egorin MJ; Erkmen K; Vlock DR; Furmanski P; Johnson CS
    Cancer Res; 1994 Oct; 54(20):5380-6. PubMed ID: 7923169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.